Emerging landscape of KRAS inhibitors in cancer treatment.

Saved in:
Bibliographic Details
Title: Emerging landscape of KRAS inhibitors in cancer treatment.
Authors: Riedl JM; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA, USA; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Matsubara H; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA, USA., McNeil R; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA, USA., Patel PS; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA, USA., Fece de la Cruz F; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA, USA., Gulhan DC; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA, USA., Corcoran RB; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA, USA. Electronic address: rbcorcoran@mgb.org.
Source: Cancer cell [Cancer Cell] 2026 Mar 09; Vol. 44 (3), pp. 471-497. Date of Electronic Publication: 2026 Jan 29.
Publication Type: Journal Article; Review
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-3686
DOI:10.1016/j.ccell.2026.01.001